Fundraising Fox高光制药
1 known investors
Find your way into 高光制药
Sign up to see every warm intro you have to 高光制药
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 高光制药 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Highlight Pharma (高光制药) is a clinical-stage biopharmaceutical company developing novel drugs for autoimmune and inflammatory diseases of the peripheral and central nervous systems. Its pipeline includes selective dual TYK2/JAK1 inhibitors and NLRP3-targeting candidates for conditions such as chronic spontaneous urticaria, rheumatoid arthritis, and neurodegenerative diseases.
Investors · 1
Frequently asked questions
- What does 高光制药 do?
- Highlight Pharma (高光制药) is a clinical-stage biopharmaceutical company developing novel drugs for autoimmune and inflammatory diseases of the peripheral and central nervous systems. Its pipeline includes selective dual TYK2/JAK1 inhibitors and NLRP3-targeting candidates for conditions such as chronic spontaneous urticaria, rheumatoid arthritis, and neurodegenerative diseases.
- Who are 高光制药's investors?
- 高光制药's investors include EFung Capital.